2024
Multi-center retrospective review of vitiligo-like lesions in breast cancer patients treated with cyclin-dependent kinase 4 and 6 inhibitors
Bang A, Fay C, LeBoeuf N, Etaee F, Leventhal J, Sibaud V, Arbesman J, Wang J, Kwong B. Multi-center retrospective review of vitiligo-like lesions in breast cancer patients treated with cyclin-dependent kinase 4 and 6 inhibitors. Breast Cancer Research And Treatment 2024, 204: 643-647. PMID: 38224427, DOI: 10.1007/s10549-023-07217-2.Peer-Reviewed Original ResearchVitiligo-like lesionsProgression-free survivalSurvival benefitMedian progression-free survivalAssociated with survival benefitSkin-directed therapiesMetastatic breast cancerSun-exposed areasPotential treatment optionCyclin-dependent kinase 4ConclusionClinical characteristicsMild repigmentationRuxolitinib creamTopical ruxolitinibMethodsRetrospective reviewResultsMedian ageClinical characteristicsCase reportTreatment optionsBreast cancerKinase inhibitorsCDK4/6iInternational cohortPatientsQuality of life
2017
Breast cancer research in Iran: a scientometric analysis of publications output from 1991 to 2015 in Scopus
Zarei M, Bagheri-Saweh M, Rasolabadi M, Vakili R, Seidi J, Kalhor M, Etaee F, Gharib A. Breast cancer research in Iran: a scientometric analysis of publications output from 1991 to 2015 in Scopus. Electronic Physician 2017, 9: 3816-3822. PMID: 28465812, PMCID: PMC5410911, DOI: 10.19082/3816.Peer-Reviewed Original Research